{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T07:52:33Z","timestamp":1766908353473,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National key research and development program","doi-asserted-by":"crossref","award":["2018YFC1002501"],"award-info":[{"award-number":["2018YFC1002501"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Major Research Plan of the Provincial Science and Technology Foundation of Guangxi","award":["Grant No.AB16380214"],"award-info":[{"award-number":["Grant No.AB16380214"]}]},{"name":"\u201cYUMIAOJIHUA\u201d Project of The Maternal & Child Health Hospital of Guangxi Zhuang Autonomous Region","award":["GXWCH-YMJH-2017005"],"award-info":[{"award-number":["GXWCH-YMJH-2017005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Neuronal ceroid lipofuscinosis type 5 (CLN5) is a rare form of neuronal ceroid lipofuscinoses (NCLs) which are a group of inherited neurodegenerative diseases characterized by progressive intellectual and motor deterioration, visual failure, seizures, behavioral changes and premature death. CLN5 was initially named Finnish variant late infantile NCL, it is now known to be present in other ethnic populations and with variable age of onset. Few CLN5 patients had been reported in Chinese population.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>In this paper, we report the symptoms of a Chinese patient who suffer from developmental regression and grand mal epilepsy for several years. The DNA was extracted from peripheral blood of proband and both parents, and then whole exome sequencing was performed using genomic DNA. Both sequence variants and copy number variants (CNVs) were analyzed and classified according to guidelines. As the result, a novel frameshift mutation c.718_719delAT\/p.Met240fs in <jats:italic>CLN5<\/jats:italic> and a de novo large deletion at 13q21.33-q31.1 which unmasked the frameshift mutation were identified in the proband. Despite the large de novo deletion, which can be classified as a pathogenic copy number variant (CNV), the patient\u2019s clinical presentation is mostly consistent with that of CLN5, except for early developmental delay which is believed due to the large deletion. Both variants were detected simultaneously by exome sequencing.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This is the first report of whole gene deletion in combination with a novel pathogenic sequence variant in a CLN5 patient. The two mutations detected with whole exome sequencing simultaneously proved the advantage of the sequencing technology for genetic diagnostics.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12881-020-01039-5","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T13:02:55Z","timestamp":1589202175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A novel pathogenic frameshift variant unmasked by a large de novo deletion at 13q21.33-q31.1 in a Chinese patient with neuronal ceroid lipofuscinosis type 5"],"prefix":"10.1186","volume":"21","author":[{"given":"Wei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zailong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiasun","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingrong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5820-0839","authenticated-orcid":false,"given":"Yiping","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"issue":"7","key":"1039_CR1","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.braindev.2016.01.004","volume":"38","author":"Y Niida","year":"2016","unstructured":"Niida Y, Yokoi A, Kuroda M, Mitani Y, Nakagawa H, Ozaki M. A girl with infantile neuronal ceroid lipofuscinosis caused by novel PPT1 mutation and paternal uniparental isodisomy of chromosome 1. Brain and Development. 2016;38(7):674\u20137.","journal-title":"Brain and Development"},{"issue":"9","key":"1039_CR2","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1093\/hmg\/ddx074","volume":"26","author":"M Segal-Salto","year":"2017","unstructured":"Segal-Salto M, Hansson K, Sapir T, Kaplan A, Levy T, Schweizer M, et al. Proteomics insights into infantile neuronal ceroid lipofuscinosis (CLN1) point to the involvement of cilia pathology in the disease. Hum Mol Genet. 2017;26(9):1678.","journal-title":"Hum Mol Genet"},{"issue":"10 Pt B","key":"1039_CR3","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","volume":"1852","author":"SE Mole","year":"2015","unstructured":"Mole SE, Cotman SL. Genetics of the neuronal ceroid lipofuscinoses (Batten disease). Biochim Biophys Acta. 2015;1852(10 Pt B):2237\u201341.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"1039_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/975","volume":"19","author":"M Savukoski","year":"1998","unstructured":"Savukoski M, Klockars T, Holmberg V, Santavuori P, Lander ES, Peltonen L. CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Nat Genet. 1998;19(3):286\u20138.","journal-title":"Nat Genet"},{"issue":"11","key":"1039_CR5","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/j.bbadis.2013.03.017","volume":"1832","author":"V Warrier","year":"2013","unstructured":"Warrier V, Vieira M, Mole SE. Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses. Biochim Biophys Acta. 2013;1832(11):1827\u201330.","journal-title":"Biochim Biophys Acta"},{"issue":"24","key":"1039_CR6","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1002\/elps.201200472","volume":"33","author":"SE Haddad","year":"2012","unstructured":"Haddad SE, Khoury M, Daoud M, Kantar R, Harati H, Mousallem T, et al. CLN5 and CLN8 protein association with ceramide synthase: biochemical and proteomic approaches. Electrophoresis. 2012;33(24):3798\u2013809.","journal-title":"Electrophoresis."},{"issue":"8","key":"1039_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/dmcn.13472","volume":"59","author":"SE Mole","year":"2017","unstructured":"Mole SE. The value of a comprehensive natural history in late infantile CLN5 disease. Dev Med Child Neurol. 2017;59(8):777\u20138.","journal-title":"Dev Med Child Neurol"},{"issue":"11","key":"1039_CR8","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/(SICI)1097-0223(199811)18:11<1169::AID-PD409>3.0.CO;2-T","volume":"18","author":"I Jarvela","year":"1998","unstructured":"Jarvela I, Savukoski M, Ammala P, von Koskull H. Prenatally detected paternal uniparental chromosome 13 isodisomy. Prenat Diagn. 1998;18(11):1169\u201373.","journal-title":"Prenat Diagn"},{"issue":"4","key":"1039_CR9","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1212\/01.WNL.0000151974.44980.F1","volume":"64","author":"N Pineda-Trujillo","year":"2005","unstructured":"Pineda-Trujillo N, Cornejo W, Carrizosa J, Wheeler RB, Munera S, Valencia A, et al. A CLN5 mutation causing an atypical neuronal ceroid lipofuscinosis of juvenile onset. Neurology. 2005;64(4):740\u20132.","journal-title":"Neurology."},{"issue":"7","key":"1039_CR10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1212\/WNL.0b013e3181cff70d","volume":"74","author":"W Xin","year":"2010","unstructured":"Xin W, Mullen TE, Kiely R, Min J, Feng X, Cao Y, et al. CLN5 mutations are frequent in juvenile and late-onset non-Finnish patients with NCL. Neurology. 2010;74(7):565\u201371.","journal-title":"Neurology."},{"issue":"43","key":"1039_CR11","first-page":"3504","volume":"96","author":"SC Ren","year":"2016","unstructured":"Ren SC, Gao BQ, Wang YJ, Wu XJ, Tian ZX, Sun YL. Clinical, genetic and pathological features of neuronal ceroid lipofuscinosis in 5 Chinese patients. Zhonghua Yi Xue Za Zhi. 2016;96(43):3504\u20137.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"5","key":"1039_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"2","key":"1039_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1055\/s-2008-1071423","volume":"22","author":"P Santavuori","year":"1991","unstructured":"Santavuori P, Rapola J, Nuutila A, Raininko R, Lappi M, Launes J, et al. The spectrum of Jansky-Bielschowsky disease. Neuropediatrics. 1991;22(2):92\u20136.","journal-title":"Neuropediatrics."},{"issue":"3","key":"1039_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1055\/s-2008-1059612","volume":"13","author":"P Santavuori","year":"1982","unstructured":"Santavuori P, Rapola J, Sainio K, Raitta C. A variant of Jansky-Bielschowsky disease. Neuropediatrics. 1982;13(3):135\u201341.","journal-title":"Neuropediatrics."},{"issue":"5","key":"1039_CR15","doi-asserted-by":"publisher","first-page":"E651","DOI":"10.1002\/humu.21010","volume":"30","author":"AH Lebrun","year":"2009","unstructured":"Lebrun AH, Storch S, Ruschendorf F, Schmiedt ML, Kyttala A, Mole SE, et al. Retention of lysosomal protein CLN5 in the endoplasmic reticulum causes neuronal ceroid lipofuscinosis in Asian sibship. Hum Mutat. 2009;30(5):E651\u201361.","journal-title":"Hum Mutat"},{"issue":"3","key":"1039_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ymgme.2006.04.010","volume":"89","author":"C Bessa","year":"2006","unstructured":"Bessa C, Teixeira CA, Mangas M, Dias A, Sa Miranda MC, Guimaraes A, et al. Two novel CLN5 mutations in a Portuguese patient with vLINCL: insights into molecular mechanisms of CLN5 deficiency. Mol Genet Metab. 2006;89(3):245\u201353.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"1039_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1177\/0883073810387298","volume":"26","author":"MK Al-Kowari","year":"2011","unstructured":"Al-Kowari MK, Hassan S, El-Said MF, Ben-Omran T, Hedin L, Mole SE, et al. Neuronal ceroid lipofuscinosis in Qatar: report of a novel mutation in ceroid-lipofuscinosis, neuronal 5 in the Arab population. J Child Neurol. 2011;26(5):625\u20139.","journal-title":"J Child Neurol"},{"issue":"3","key":"1039_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1399-0004.2008.01054.x","volume":"74","author":"SJ Moore","year":"2008","unstructured":"Moore SJ, Buckley DJ, MacMillan A, Marshall HD, Steele L, Ray PN, et al. The clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in Newfoundland. Clin Genet. 2008;74(3):213\u201322.","journal-title":"Clin Genet"},{"issue":"4","key":"1039_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1212\/WNL.55.4.579","volume":"55","author":"V Holmberg","year":"2000","unstructured":"Holmberg V, Lauronen L, Autti T, Santavuori P, Savukoski M, Uvebrant P, et al. Phenotype-genotype correlation in eight patients with Finnish variant late infantile NCL (CLN5). Neurology. 2000;55(4):579\u201381.","journal-title":"Neurology."},{"issue":"8","key":"1039_CR20","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/dmcn.13473","volume":"59","author":"A Simonati","year":"2017","unstructured":"Simonati A, Williams RE, Nardocci N, Laine M, Battini R, Schulz A, et al. Phenotype and natural history of variant late infantile ceroid-lipofuscinosis 5. Dev Med Child Neurol. 2017;59(8):815\u201321.","journal-title":"Dev Med Child Neurol"},{"issue":"9","key":"1039_CR21","first-page":"544","volume":"54","author":"MS Perez-Poyato","year":"2012","unstructured":"Perez-Poyato MS, Mila-Recasens M, Ferrer-Abizanda I, Cusi-Sanchez V, Vazquez-Lopez M. Camino-Leon R et al: [neuronal ceroid lipofuscinosis: diagnostic algorithm and clinical description of the Finnish (CLN5) and Turkish (CLN7) variants late infantile]. Rev Neurol. 2012;54(9):544\u201350.","journal-title":"Rev Neurol"},{"issue":"3","key":"1039_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10048-005-0218-3","volume":"6","author":"SE Mole","year":"2005","unstructured":"Mole SE, Williams RE, Goebel HH. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics. 2005;6(3):107\u201326.","journal-title":"Neurogenetics."},{"issue":"1","key":"1039_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00415-014-7553-y","volume":"262","author":"C Mancini","year":"2015","unstructured":"Mancini C, Nassani S, Guo Y, Chen Y, Giorgio E, Brussino A, et al. Adult-onset autosomal recessive ataxia associated with neuronal ceroid lipofuscinosis type 5 gene (CLN5) mutations. J Neurol. 2015;262(1):173\u20138.","journal-title":"J Neurol"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-020-01039-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12881-020-01039-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-020-01039-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T23:50:13Z","timestamp":1620690613000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-020-01039-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1039"],"URL":"https:\/\/doi.org\/10.1186\/s12881-020-01039-5","relation":{},"ISSN":["1471-2350"],"issn-type":[{"type":"electronic","value":"1471-2350"}],"subject":[],"published":{"date-parts":[[2020,5,11]]},"assertion":[{"value":"11 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study were reviewed and approved by the ethics committee of Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region. Detailed written informed consent was obtained from all participants, and this study adhered to the tenets of the Declaration of Helsinki. Since the proband of this article is a minor with cognitive impairment and disability, written informed consent for participation in this study was obtained from the parents or guardians of patient.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient and his parents of this report for the use of clinical-related materials for scientific research and publications. A copy is available to the journal if needed. These materials include characteristic phenotypic images, treatment and prognostic information, genetic testing results and other related data used in this report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors have any competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}